COVID-19 Daily News: June 11
Mayo Clinic launches neutralizing antibody test to advance COVID-19 therapies
ROCHESTER, Minn. — Mayo Clinic has launched a new SARS-CoV-2 neutralizing antibody test in support of the national Expanded Access Program for Convalescent Plasma and other critical research efforts to establish effective therapies and vaccines for COVID-19. The test will be available through Mayo Clinic Laboratories to select labs, blood banks, and biopharma clients in late June.
Who should get COVID-19 testing?
Dr. Bobbi Pritt, a clinical microbiologist at Mayo Clinic, acknowledges that there seems to be a lot of confusion with the general public when it comes to COVID-19 testing. Terms like viral, molecular, serology and antibodies, and convalescent plasma have sprung up in everyday language when talking about COVID-19 — but do you really need to know all of these terms or is it just causing more confusion? Let’s break it down to what you need to know and why it’s important for you.
Innovation in COVID-19 Testing: Dr. Bill Morice
William Morice, II, M.D., Ph.D., Chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and President of Mayo Clinic Laboratories, joins the Answers from the Lab podcast for his weekly leadership update. On this episode, Dr. Morice discusses the launch of our new neutralizing antibody assay. He also provides a six-month update on where we are today with COVID-19, and the challenges of balancing testing demand with available resources.